All Stories

  1. Development and partial characterization of fused human endostatin

    Article • Protein Expression and Purification, July 2026, Elsevier

    Prof. Abhay Hariram Pande

  2. Engineering and Partial Characterization of an Anti-IL-23/Anti-TNF-α Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy

    Article • Applied Biochemistry and Biotechnology, April 2026, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  3. The rise of bispecific T-cell engager (BsTCE) antibodies: A potentially game-changing approach for breast cancer therapy?

    Article • Drug Discovery Today, April 2026, Elsevier

    Prof. Abhay Hariram Pande

  4. Journey of therapeutic antibodies: from discovery to future

    Article • Exploration of Drug Science, March 2026, Open Exploration Publishing

    Prof. Abhay Hariram Pande

  5. Lignin-based biopharmaceuticals from nature to medicine: current trends, future prospects and emerging challenges

    Article • RSC Applied Interfaces, January 2026, Royal Society of Chemistry

    Prof. Abhay Hariram Pande

  6. Correction: Photosensitizer-Antibody Conjugates (PhotoBodies): Emerging Frontiers in the Field of Theranostics

    Article • Pharmaceutical Research, January 2026, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  7. Nanophotobody-mediated EGFR targeting using lignin nanoassemblies enhances photodynamic efficacy in breast cancer

    Article • RSC Pharmaceutics, January 2026, Royal Society of Chemistry

    Prof. Abhay Hariram Pande

  8. Radioligand–Antibody Conjugates: Integrating Antibody Engineering, Chelator Chemistry, and Radioligands for Precision Theranosis

    Article • Molecular Diagnosis & Therapy, December 2025, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  9. Photosensitizer-Antibody Conjugates (PhotoBodies): Emerging Frontiers in the Field of Theranostics

    Article • Pharmaceutical Research, December 2025, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  10. Polybodies for the treatment of respiratory syncytial virus infection

    Article • Drug Discovery Today, December 2025, Elsevier

    Prof. Abhay Hariram Pande

  11. Chemotherapeutic Drug—Antibody Conjugates (ChemoBodies): Recent Advances and Future Directions

    Article • Current Oncology Reports, October 2025, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  12. Challenges and advances in the development of antidotes against A-series nerve agents

    Article • Archives of Toxicology, October 2025, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  13. Efficacy and safety of transcutaneous electrical nerve stimulation versus oxybutynin in the treatment of overactive bladder in children: a systematic review and meta-analysis

    Article • International Urology and Nephrology, July 2025, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  14. Cardioprotective Potential of ApoE-Derived Peptide (ApoEFrag) in Myocardial Infarction in Rats: A Mechanistic Study

    Article • ACS Pharmacology & Translational Science, July 2025, American Chemical Society (ACS)

    Prof. Abhay Hariram Pande

  15. Amino acid deprivation vs. mainstream cancer therapeutics: exploring the potential and limitations

    Article • Future Oncology, May 2025, Taylor & Francis

    Prof. Abhay Hariram Pande

  16. Human Paraoxonase 1: From Bloodstream Enzyme to Disease Fighter & Therapeutic Intervention

    Article • Current Protein and Peptide Science, May 2025, Bentham Science Publishers

    Prof. Abhay Hariram Pande

  17. Neuroprotective potential of ApoE-mimetic peptide (ApoEFrag) in stroke models: Neurobehavioural and mechanistic study

    Article • International Journal of Biological Macromolecules, April 2025, Elsevier

    Prof. Abhay Hariram Pande

  18. Bispecific domain antibody attenuates airway hyperresponsiveness and pulmonary inflammation in ovalbumin-lipopolysaccharide induced asthma model by inhibiting IL-23 and TNF-α

    Article • Pulmonary Pharmacology & Therapeutics, March 2025, Elsevier

    Prof. Abhay Hariram Pande

  19. Nanobody-Oligonucleotide Conjugates (NucleoBodies): The Next Frontier in Oligonucleotide Therapy

    Article • Pharmaceutical Research, February 2025, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  20. What are biopharmaceuticals?

    Article • January 2025, Open Exploration Publishing

    Prof. Abhay Hariram Pande

  21. ApoE potential in CNS drugs targeting and as CNS therapeutic

    Article • January 2025, Elsevier

    Prof. Abhay Hariram Pande

  22. Antigen Specificity: A Fluctuating Aspect in the Development of Clinical Antibodies?

    Article • Apmis, January 2025, Wiley

    Prof. Abhay Hariram Pande

  23. Therapeutic Use of ApoE-Mimetic Peptides

    Article • January 2025, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  24. Endostatin in disease modulation: From cancer to beyond

    Article • Vascular Pharmacology, December 2024, Elsevier

    Prof. Abhay Hariram Pande

  25. Role of paraoxonase 1 in organophosphate G-series nerve agent poisoning and future therapeutic strategies

    Article • Archives of Toxicology, October 2024, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  26. Polybodies: Next-generation clinical antibodies

    Article • Drug Discovery Today, October 2024, Elsevier

    Prof. Abhay Hariram Pande

  27. Broad-spectrum anti-cancer activity of fused human arginase variants

    Article • Investigational New Drugs, August 2024, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  28. Warfare Nerve Agents and Paraoxonase-1 as a Potential Prophylactic Therapy against Intoxication

    Article • Protein & Peptide Letters, May 2024, Bentham Science Publishers

    Prof. Abhay Hariram Pande

  29. Molecular and functional insight into anti-EGFR nanobody: Theranostic implications for malignancies

    Article • Life Sciences, May 2024, Elsevier

    Prof. Abhay Hariram Pande

  30. Treating liver cancer through arginine depletion

    Article • Drug Discovery Today, March 2024, Elsevier

    Prof. Abhay Hariram Pande

  31. Polyvalency: an emerging trend in the development of clinical antibodies

    Article • Drug Discovery Today, January 2024, Elsevier

    Prof. Abhay Hariram Pande

  32. Towards development of biobetter: L-asparaginase a case study

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, January 2024, Elsevier

    Prof. Abhay Hariram Pande

  33. Catalysing and Accelerating a New Phase in Indian Biopharma

    Article • January 2024, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  34. Engineered polyspecific antibodies: A new frontier in the field of immunotherapeutics

    Article • Immunology, December 2023, Wiley

    Prof. Abhay Hariram Pande

  35. Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status

    Article • Medical Oncology, December 2023, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  36. Development and characterization of fused human arginase I for cancer therapy

    Article • Investigational New Drugs, August 2023, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  37. Human arginase I: a potential broad-spectrum anti-cancer agent

    Article • 3 Biotech, May 2023, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  38. Fused human paraoxonase 1 as a prophylactic agent against organophosphate poisoning

    Article • Enzyme and Microbial Technology, April 2023, Elsevier

    Prof. Abhay Hariram Pande

  39. Polyspecificity - An emerging trend in the development of clinical antibodies

    Article • Molecular Immunology, March 2023, Elsevier

    Prof. Abhay Hariram Pande

  40. Paraoxonase 1 as a potential prophylactic against nerve agent poisoning

    Article • January 2023, Elsevier

    Prof. Abhay Hariram Pande

  41. Types of Wound Dressings and Materials used in Mild to Moderately Exuding Wounds: A Review

    Article • International Journal of Health Technology and Innovation, December 2022, Kalam Institute of Health Technology

    Prof. Abhay Hariram Pande

  42. Apolipoprotein-mimetic Peptides: Current and Future Prospectives

    Article • Current Protein and Peptide Science, November 2022, Bentham Science Publishers

    Prof. Abhay Hariram Pande

  43. Immunomodulatory potential of apolipoproteins and their mimetic peptides in asthma: Current perspective

    Article • Respiratory Medicine, November 2022, Elsevier

    Prof. Abhay Hariram Pande

  44. Human arginase 1, a Jack of all trades?

    Article • 3 Biotech, September 2022, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  45. Therapeutic potential of ApoE-mimetic peptides in CNS disorders: Current perspective

    Article • Experimental Neurology, July 2022, Elsevier

    Prof. Abhay Hariram Pande

  46. HDL, ApoA-I and ApoE-Mimetic Peptides: Potential Broad Spectrum Agent for Clinical Use?

    Article • International Journal of Peptide Research and Therapeutics, January 2022, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  47. Optimization of medium composition to increase the expression of recombinant human interferon-β using the Plackett–Burman and central composite design in E. coli SE1

    Article • 3 Biotech, April 2021, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  48. Human Arginase I (Arg I)—A Potential Broad-spectrum Anti-cancer Agent: Perspectives and the Road Ahead

    Article • Research & Reviews Journal of Oncology and Hematology, December 2020, Consortium eLearning Network Pvt Ltd

    Prof. Abhay Hariram Pande

  49. APOE-Derived Peptides Attenuated Diabetes-Induced Oxidative Stress and Inflammation

    Article • Protein & Peptide Letters, October 2019, Bentham Science Publishers

    Prof. Abhay Hariram Pande

  50. Is Human Paraoxonase 1 the Saviour Against the Persistent Threat of Organophosphorus Nerve Agents?

    Article • Protein & Peptide Letters, July 2019, Bentham Science Publishers

    Prof. Abhay Hariram Pande

  51. Protein Chimerization: A New Frontier for Engineering Protein Therapeutics with Improved Pharmacokinetics

    Article • Journal of Pharmacology and Experimental Therapeutics, April 2019, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Prof. Abhay Hariram Pande

  52. Antibiotic-free expression system for the production of human interferon-beta protein

    Article • 3 Biotech, December 2017, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  53. Towards Understanding the Catalytic Mechanism of Human Paraoxonase 1: Experimental and In Silico Mutagenesis Studies

    Article • Applied Biochemistry and Biotechnology, February 2017, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  54. Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead

    Article • The Protein Journal, November 2016, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  55. Refolded Recombinant Human Paraoxonase 1 Variant Exhibits Prophylactic Activity Against Organophosphate Poisoning

    Article • Applied Biochemistry and Biotechnology, April 2016, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  56. Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192

    Article • PLOS One, February 2016, PLOS

    Prof. Abhay Hariram Pande

  57. Abstract 12419: Preclinical Safety and Efficacy of a Novel Thrombolytic Agent Administered by Rapid Bolus Injection: Clot Specific Streptokinase (CSSK/SMRX-11)

    Article • Circulation, November 2015, Wolters Kluwer Health

    Prof. Abhay Hariram Pande

  58. Improving Properties of Recombinant SsoPox by Site-Specific Pegylation

    Article • Protein & Peptide Letters, November 2015, Bentham Science Publishers

    Prof. Abhay Hariram Pande

  59. Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli

    Article • Protein Expression and Purification, November 2015, Elsevier

    Prof. Abhay Hariram Pande

  60. Expression, purification and immobilization of recombinant AiiA enzyme onto magnetic nanoparticles

    Article • Protein Expression and Purification, September 2015, Elsevier

    Prof. Abhay Hariram Pande

  61. Improving storage stability of recombinant organophosphorus hydrolase

    Article • Protein Expression and Purification, July 2015, Elsevier

    Prof. Abhay Hariram Pande

  62. Interplay between amino acid residues at positions 192 and 115 in modulating hydrolytic activities of human paraoxonase 1

    Article • Biochimie, October 2014, Elsevier

    Prof. Abhay Hariram Pande

  63. Properties of apolipoprotein E derived peptide modulate their lipid-binding capacity and influence their anti-inflammatory function

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, April 2014, Elsevier

    Prof. Abhay Hariram Pande

  64. Stabilization Studies on Bacterially Produced Human Paraoxonase 1 for Improving Its Shelf Life

    Article • Applied Biochemistry and Biotechnology, February 2014, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  65. Human Paraoxonase 1 as a Pharmacologic Agent: Limitations and Perspectives

    Article • The Scientific World JOURNAL, January 2014, Hindawi Publishing Corporation

    Prof. Abhay Hariram Pande

  66. Apolipoprotein E Derived Peptides Inhibit the Pro-Inflammatory Effect of Lysophosphatidylcholine

    Article • Protein & Peptide Letters, December 2013, Bentham Science Publishers

    Prof. Abhay Hariram Pande

  67. Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, December 2013, Elsevier

    Prof. Abhay Hariram Pande

  68. Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme

    Article • Protein Science, October 2013, Wiley

    Prof. Abhay Hariram Pande

  69. Differential interaction of peptides derived from C-terminal domain of human apolipoprotein E with platelet activating factor analogs

    Article • Biochimie, June 2013, Elsevier

    Prof. Abhay Hariram Pande

  70. The Chemical Nature of the Polar Functional Group of Oxidized Acyl Chain Uniquely Modifies the Physicochemical Properties of Oxidized Phospholipid-Containing Lipid Particles

    Article • The Journal of Membrane Biology, May 2013, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  71. Physicochemical properties of bacterial pro-inflammatory lipids influence their interaction with apolipoprotein-derived peptides

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, April 2013, Elsevier

    Prof. Abhay Hariram Pande

  72. Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, September 2012, Elsevier

    Prof. Abhay Hariram Pande

  73. Characterization of Oxidized Phospholipid containing Reconstituted High Density Lipoprotein Particle

    Article • Biophysical Journal, January 2012, Elsevier

    Prof. Abhay Hariram Pande

  74. A Therapeutic Chemical Chaperone Inhibits Cholera Intoxication and Unfolding/Translocation of the Cholera Toxin A1 Subunit

    Article • PLOS One, April 2011, PLOS

    Professor Fernando Navarro-Garcia, Prof. Abhay Hariram Pande

  75. Closely related oxidized phospholipids differentially modulate the physicochemical properties of lipid particles

    Article • Chemistry and Physics of Lipids, January 2011, Elsevier

    Prof. Abhay Hariram Pande

  76. Membrane lipid composition differentially modulates the function of human plasma platelet activating factor-acetylhydrolase

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, January 2011, Elsevier

    Prof. Abhay Hariram Pande

  77. Contribution of Subdomain Structure to the Thermal Stability of the Cholera Toxin A1 Subunit

    Article • Biochemistry, September 2010, American Chemical Society (ACS)

    Prof. Abhay Hariram Pande

  78. Oxidatively modified fatty acyl chain determines physicochemical properties of aggregates of oxidized phospholipids

    Article • Biochimica et Biophysica Acta (BBA) - Biomembranes, March 2010, Elsevier

    Prof. Abhay Hariram Pande

  79. Stabilization of the Tertiary Structure of the Cholera Toxin A1 Subunit Inhibits Toxin Dislocation and Cellular Intoxication

    Article • Journal of Molecular Biology, November 2009, Elsevier

    Prof. Abhay Hariram Pande

  80. Peptide derived from the lipid binding domain of Group IB human pancreatic phospholipase A2 possesses antibacterial activity

    Article • Biochimie, November 2009, Elsevier

    Prof. Abhay Hariram Pande

  81. Membrane surface charge modulates lipoprotein complex forming capability of peptides derived from the C-terminal domain of apolipoprotein E

    Article • Biochimica et Biophysica Acta (BBA) - Biomembranes, June 2009, Elsevier

    Prof. Abhay Hariram Pande

  82. Preferential binding of apolipoprotein E derived peptides with oxidized phospholipid

    Article • Biochemical and Biophysical Research Communications, February 2009, Elsevier

    Prof. Abhay Hariram Pande

  83. Bax C-Terminal Peptide - Insights Into Membrane Interactions

    Article • Biophysical Journal, February 2009, Elsevier

    Prof. Abhay Hariram Pande

  84. Conformational Instability of the Cholera Toxin A1 Polypeptide

    Article • Journal of Molecular Biology, December 2007, Elsevier

    Prof. Abhay Hariram Pande

  85. The Pertussis Toxin S1 Subunit Is a Thermally Unstable Protein Susceptible to Degradation by the 20S Proteasome

    Article • Biochemistry, October 2006, American Chemical Society (ACS)

    Prof. Abhay Hariram Pande

  86. Isoform-Specific Membrane Insertion of Secretory Phospholipase A2 and Functional Implications

    Article • Biochemistry, September 2006, American Chemical Society (ACS)

    Prof. Abhay Hariram Pande

  87. Structural and Functional Effects of Tryptophans Inserted into the Membrane-binding and Substrate-binding Sites of Human Group IIA Phospholipase A2

    Article • Biochemistry, September 2006, American Chemical Society (ACS)

    Prof. Abhay Hariram Pande

  88. Carbohydrate-induced modulation of cell membrane. VIII. Agglutination with mammalian lectin galectin-1 increases osmofragility and membrane fluidity of trypsinized erythrocytes

    Article • FEBS Letters, February 2006, Wiley

    Prof. Abhay Hariram Pande

  89. Evidence for the Regulatory Role of the N-terminal Helix of Secretory Phospholipase A2 from Studies on Native and Chimeric Proteins

    Article • Journal of Biological Chemistry, November 2005, Elsevier

    Prof. Abhay Hariram Pande

  90. Positioning Membrane Proteins by Novel Protein Engineering and Biophysical Approaches

    Article • Journal of Molecular Biology, September 2005, Elsevier

    Prof. Abhay Hariram Pande

  91. Membrane Fluidity Is a Key Modulator of Membrane Binding, Insertion, and Activity of 5-Lipoxygenase

    Article • Biophysical Journal, June 2005, Elsevier

    Prof. Abhay Hariram Pande

  92. Modulation of Human 5-Lipoxygenase Activity by Membrane Lipids, by

    Article • Biochemistry, December 2004, American Chemical Society (ACS)

    Prof. Abhay Hariram Pande

  93. The N-terminal α-Helix of Pancreatic Phospholipase A2 Determines Productive-mode Orientation of the Enzyme at the Membrane Surface

    Article • Journal of Molecular Biology, November 2004, Elsevier

    Prof. Abhay Hariram Pande

  94. Modulation of Human 5-Lipoxygenase Activity by Membrane Lipids

    Article • Biochemistry, October 2004, American Chemical Society (ACS)

    Prof. Abhay Hariram Pande

  95. Oxidation of Goat Hepatic Galectin-1 Induces Change in Secondary Structure

    Article • Protein & Peptide Letters, June 2003, Bentham Science Publishers

    Prof. Abhay Hariram Pande

  96. Involvement of a Nine-residue Loop of Streptokinase in the Generation of Macromolecular Substrate Specificity by the Activator Complex through Interaction with Substrate Kringle Domains

    Article • Journal of Biological Chemistry, April 2002, Elsevier

    Prof. Abhay Hariram Pande

  97. Studies on a Doubleheaded Protease Inhibitor from Phaseolus mungo

    Article • Journal of Plant Biochemistry and Biotechnology, January 1999, Springer Science + Business Media

    Prof. Abhay Hariram Pande

  98. Carbohydrate induced modulation of cell membrane VII. Binding of exogenous lectin increases osmofragility of erythrocytes

    Article • FEBS Letters, May 1998, Wiley

    Prof. Abhay Hariram Pande

  99. Carbohydrate induced modulation of cell membrane. VI. Binding of exogenous lectin induces susceptibility of erythrocytes to free radical damage: a spin label study

    Article • FEBS Letters, April 1997, Wiley

    Prof. Abhay Hariram Pande